Hedgehog signaling in human hepatocellular carcinoma

Cancer Biology and Therapy

Volumn 5, Issue 1, 2006, Pages 111-117

  Patil, Mohini A ^a   Zhang, Ji ^a,b   Ho, Coral ^a   Cheung, Siu Tim ^c   Fan, Sheung Tat ^c   Chen, Xin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cyclopamine; HCC; Hedgehog

Indexed keywords

CYCLIN D; CYCLOPAMINE; HEDGEHOG INTERACTING PROTEIN 1; MYC PROTEIN; PROTEIN; SMOOTHENED TRANSMEMBRANE PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 32544437230     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.5.1.2379     Document Type: Article

References (48)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2:533-43.
2. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988; 61:1942-56.
3. Bruno S, Silini E, Crosignani A, Borzio F, Leandro G, Bono F, Asti M, Rossi S, Larghi A, Cerino A, Podda M and Mondelli MU. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 1997; 25:754-8.
4. El-Serag HB and Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000; 160:3227-30.
5. Buendia MA. Genetics of hepatocellular carcinoma. Semin Cancer Biol 2000; 10:185-200.
6. Lin TY, Lee CS, Chen KM and Chen CC. Role of surgery in the treatment of primary carcinoma of the liver: a 31-year experience. Br J Surg 1987; 74:839-42.
7. Helton WS, Di Bisceglie A, Chari R, Schwartz M and Bruix J. Treatment strategies for hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2003; 7:401-11.
8. Mor E, Kaspa RT, Sheiner P and SchwartzM. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998; 129:643-53.
9. Nusslein-Volhard C and Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 1980; 287:795-801.
10. Xie K and Abbruzzese JL. Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers. Cancer Cell 2003; 4:245-7.
11. Roessler E and Muenke M. How a Hedgehog might see holoprosencephaly. Hum Mol Genet 2003; 12:R15-25.
12. Ruiz i Altaba A, Sanchez P and Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer 2002; 2:361-72.
13. Nybakken K and Perrimon N. Hedgehog signal transduction: recent findings. Curr Opin Genet Dev 2002; 12:503-11.
14. Mullor JL, Sanchez P and Altaba AR. Pathways and consequences: Hedgehog signaling in human disease. Trends Cell Biol 2002; 12:562-9.
15. Hahn H, Wojnowski L, Miller G and Zimmer A. The patched signaling pathway in tumorigenesis and development: lessons from animal models. J Mol Med 1999; 77:459-68.
16. Cohen MM Jr. The hedgehog signaling network. Am J Med Genet 2003; 123A:5-28.
17. Ho KS and Scott MP. Sonic hedgehog in the nervous system: functions, modifications and mechanisms. Curr Opin Neurobiol 2002; 12:57-63.
18. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, Rosenthal A, Epstein EH Jr. and de Sauvage FJ, Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 1998; 391:90-2.
19. Evans T, Boonchai W, Shanley S, Smyth I, Gillies S, Georgas K, Wainwright B, Chenevix-Trench G and Wicking C. The spectrum of patched mutations in a collection of Australian basal cell carcinomas. Hum Mutat 2000; 16:43-8.
20. Ruiz AA I, Palma V and Dahmane N. Hedgehog-Gli signalling and the growth of the brain. Nat Rev Neurosci 2002; 3:24-33.
21. Chuang PT and McMahon AP. Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 1999; 397:617-21.
22. Zeng X, Goetz JA, Suber LM, Scott WJ Jr., Schreiner CM and Robbins DJ. A freely diffusible form of Sonic hedgehog mediates long-range signalling. Nature 2001; 411:716-20.
23. Olsen CL, Hsu PP, Glienke J, Rubanyi GM and Brooks AR. Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors. BMC Cancer 2004; 4:43.
24. Dahmane N, Lee J, Robins P, Heller P and Ruiz i Altaba A. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 1997; 389:876-81.
25. Athar M, Li C, Tang X, Chi S, Zhang X, Kim AL, Tyring SK, Kopelovich L, Hebert J, Epstein EH Jr., Bickers DR and Xie J. Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Res 2004; 64:7545-52.
26. Williams JA. Hedgehog signaling pathway as a target for therapeutic intervention in basal cell carcinoma. Drug News Perspect 2003; 16:657-62.
27. Basset-Seguin N and Soufir N. Patched/Sonic Hedgehog pathway and basal cell carcinoma. Med Sci 2004; 20:899-903.
28. Dahmane N, Sanchez P, Gitton Y, Palma V, Sun T, Beyna M, Weiner H and Ruiz i Altaba A. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 2001; 128:5201-12.
29. Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, Chen JK, Cooper MK, Taipale J, Olson JM and Beachy PA. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 2002; 297:1559-61.
30. Taipale J, Chen JK, Cooper MK, Wang B, Mann RK, Milenkovic L, Scott MP and Beachy PA. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 2000; 406:1005-9.
31. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA and Baylin SB. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003; 422:313-7.
32. Kubo M, Nakamura M, Tasaki A, Yamanaka N, Nakashima H, Nomura M, Kuroki S and Katano M. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res, 2004. 64:6071-4.
33. Sanchez P, Hernandez AM, Stecca B, Kahler AJ, DeGueme AM, Barrett A, Beyna M, Datta MW, Datta S and Ruiz i Altaba A. Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci USA 2004; 101:12561-6.
34. Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM and Beachy PA. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004; 431:707-12.
35. Sheng T, Li C, Zhang X, Chi S, He N, Chen K, McCormick F, Gatalica Z and Xie J. Activation of the hedgehog pathway in advanced prostate cancer. Mol Cancer 2004; 3:29.
36. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN and Beachy PA. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003; 425:846-51.
37. Ma X, Chen K, Huang S, Zhang X, Adegboyega PA, Evers BM, Zhang H and Xie J. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis 2005; 26:1698-705.
38. Ma X, Sheng T, Zhang Y, Zhang X, He J, Huang S, Chen K, Sultz J, Adegboyega PA, Zhang H and Xie J. Hedgehog signaling is activated in subsets of esophageal cancers. Int J Cancer 2006; 118:139-48.
39. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernandez-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL and Hebrok M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003; 425:851-6.
40. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25:169-93.
41. Leung SY, Chen X, Chu KM, Yuen ST, Mathy J, Ji J, Chan AS, Li R, Law S, Troyanskaya OG, Tu IP, Wong J, So S, Botstein D and Brown PO. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci USA 2002; 99:16203-8.
42. Chen X, Higgins J, Cheung ST, Li R, Mason V, Montgomery K, Fan ST, van de Rijn M and So S. Novel endothelial cell markers in hepatocellular carcinoma. Mod Pathol 2004; 17:1198-210.
43. Chen JK, Taipale J, Cooper MK and Beachy PA. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 2002; 16:2743-8.
44. Guan XY, Fang Y, Sham JS, Kwong DL, Zhang Y, Liang Q, Li H, Zhou H and Trent JM. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 2000; 29:110-6.
45. Wong N, Lai P, Lee SW, Fan S, Pang E, Liew CT, Sheng Z, Lau JW and Johnson PJ. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol 1999; 154:37-43.
46. Zimonjic DB, Keck CL, Thorgeirsson SS and Popescu NC. Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology 1999; 29:1208-14.
47. 47.; Patil MA, Gutgemann I, Zhang J, Ho C, Cheung ST, Ginzinger D, Li R, Dykema KJ, So S, Fan ST, Kakar S, Furge KA, Buttner R and ChenX. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 2005; 26:2050-7.
48. Martin ST, Sato N, Dhara S, Chang R, Hustinx SR, Abe T, Maitra A and Goggins M. Aberrant Methylation of the Human Hedgehog Interacting Protein (HHIP) Gene in Pancreatic Neoplasms. Cancer Biol Ther 2005; 4:728-33.